AbbVie
ABBV
#31
Rank
NZ$782.12 B
Marketcap
NZ$442.68
Share price
-1.15%
Change (1 day)
46.55%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Quarterly Reports

Thumbnail AbbVie Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail AbbVie Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail AbbVie Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report
Thumbnail AbbVie Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report
Thumbnail AbbVie Quarterly Report 2024-q3

Quarterly Report 2024-q3

Language: English

View Quarterly Report
Thumbnail AbbVie Quarterly Report 2024-q2

Quarterly Report 2024-q2

Language: English

View Quarterly Report
Thumbnail AbbVie Quarterly Report 2024-q1

Quarterly Report 2024-q1

Language: English

View Quarterly Report